Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 1990

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Genetic DisorderNoonan Syndrome
Interventions
DRUG

somatropin

Retrospective data collection based on data obtained from a prospective, open-label, randomised, parallel-group trial (S/GHD/004/NOO) combined with a present follow-up visit

DRUG

somatropin

Retrospective data collection based on data obtained from a prospective, open-label, randomised, parallel-group trial (S/GHD/004/NOO) combined with a present follow-up visit

Trial Locations (1)

416 85

Novo Nordisk Investigational Site, Gothenburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01529840 - Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome | Biotech Hunter | Biotech Hunter